• Home
  • About Us
  • Training Events
  • In The News
  • Contact Us
  • Video
  • Faq
Have any question?
Support@LeafyPros.com
Budtender TrainingBudtender Training
  • Home
  • About Us
  • Training Events
  • In The News
  • Contact Us
  • Video
  • Faq

Blog

  • Home
  • Blog
  • The DEA just made a huge change to how the government treats medical marijuana

The DEA just made a huge change to how the government treats medical marijuana

US-POLITICS

The federal government announced plans to expand cannabis research Monday, paving the way for the robust clinical trials cannabis experts believe will force the government to downgrade marijuana’s Controlled Substances Act classification.

The decision comes just two days before a key deadline in a lawsuit against the agency brought by cannabis researcher Dr. Sue Sisley of the Scottsdale Research Institute. Sisley had sought to end three years of stalling by the Drug Enforcement Agency (DEA).

Monday’s regulatory filing, and the warm remarks from Attorney General William Barr that accompanied it in a press release, effectively mean Dr. Sisley’s won. Coupled with Barr’s ardently anti-pot predecessor Jeff Sessions’ departure, progress toward the looser federal treatment of cannabis may resume.

“Until today, no one could do anything. We were handcuffed, in limbo,” said Shane Pennington, a member of Dr. Sisley’s legal team. “Now they’ve done something. It’s a huge, huge deal.”

The actual notice published in the Federal Register is characteristically dry, but it says the DEA will soon unveil a proposed regulation to govern applications to grow cannabis for scientific and medical research. For half a century, only one grow was legally approved for such purposes — a University of Mississippi facility contracted by the National Institute on Drug Abuse (NIDA).

That monopoly on production has hampered researchers like Dr. Sisley for years. The U-Miss project only produced a handful of strains of cannabis and their cultivation methods produced a low-grade flower. Dr. Sisley’s research — which probes cannabis’s potential to treat post-traumatic stress disorder and focuses on combat veterans — required product of higher quality, more consistent quality, and a wider variety of chemical makeups. The subtleties of cannabis chemistry go far beyond the THC that produces a recreational high, and some researchers believe other attributes of the plant might have various psychological and physiological benefits.

A monopoly on production for research meant NIDA and the growers in Mississippi had no incentive to deliver what Dr. Sisley and her peers wanted for their studies.

Back in 2016, the DEA claimed to be ready to smash up NIDA’s single-actor control of research cannabis back. That announcement was greeted with great fanfare in the research and drug policy communities and prompted Dr. Sisley to apply for a research-grow license from the DEA later that year.

But it was only a departmental policy. There was no follow-through. Nobody at the government would respond to her application or the dozens of others filed since. And because there were no federal regulations related to the 2016 policy memorandum, Dr. Sisley’s attorney explained, it was almost impossible to force the agency to do what it had promised.

Tag:Medical Marijuana

  • Share:
Leafy Pros

Previous post

Maryland’s Medical Marijuana Sales in 2019 on Track to Double 2018’s Output
08-27-2019

Next post

A bigger crop: Why Maryland’s medical pot growers are adding more plants
09-06-2019

You may also like

safe_image
Top Black Cannabis Entrepreneurs Cashing In On The $75 Billion Market
29 January, 2020
2MERV3V7ZNFRRAIHKLNI3YOSRU
Slow burn: Maryland medical marijuana companies fume as licensing process drags on
24 January, 2020
safe_image (1)
New York, New Jersey, Connecticut, Pennsylvania May Coordinate a Unified Adult-Use Legalization Plan
10 January, 2020

Leave A Reply Cancel reply

Your email address will not be published. Required fields are marked *

Error:Error validating access token: The session has been invalidated because the user changed their password or Facebook has changed the session for security reasons.

logo-eduma-the-best-lms-wordpress-theme

Support@LeafyPros.com

facebook twitter instagram youtube

Links

  • Training Events
  • FAQS
  • Video

Company

  • About Us
  • Contact Us
  • In The News
Tweets by @LeafyPros

© 2019 Leafy Pros All Right Reserved.

  • Designed and Developed By: Binary Data

x